Skip to content

Restart Anticoagulation in Patients With Spontaneous Intracerebral Hemorrhage and Mechanical Heart Valves

Restart Anticoagulation in Patients With Spontaneous Intracerebral Hemorrhage and Mechanical Heart Valves

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04450446
Enrollment
100
Registered
2020-06-29
Start date
2015-01-01
Completion date
2020-08-31
Last updated
2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Hemorrhage

Brief summary

The investigators retrospectively reviewed the electronic medical records of the patients with spontaneous cerebral hemorrhage and mechanical valves from 2015 to 2020 in the second affiliated hospital of Zhejiang university medical college. Medical documents and patient data were reviewed, including patient age, gender, type of mechanical heart valve, replacement time, replacement site, underlying disease, anticoagulant drugs at admission, type of cerebral hemorrhage, treatment mode, time without anticoagulant, length of stay, mortality, etc

Interventions

DRUGLow molecular weight heparin

Anticoagulation therapy

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with spontaneous cerebral hemorrhage and mechanical valves

Exclusion criteria

* age\<18y * pregnant patients * death in 24 hours without anticoagulant

Design outcomes

Primary

MeasureTime frameDescription
survival and death patients after follow-up investigation for 60 months2015-2020the patients with spontaneous cerebral hemorrhage and mechanical valves in the second affiliated hospital of Zhejiang university medical college.

Countries

China

Contacts

Primary Contactrubin luo, MD
keyanlunli_zheer@163.com+86057187783759

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026